NeoGuide
2000
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
Description
Developer of robotic endoscopic technology for natural orifice transluminal endoscopic surgery (NOTES). The company develops robotic endoscopic technology for the emerging area of Natural Orifice Transluminal Endoscopic Surgery (NOTES) and technology designed to revolutionize the way physicians visualize and deliver therapies within the body.
Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Acquirer
Primary Office
- 2712 Orchard Parkway
- San Jose, CA 95134
- United States
+1 (408) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore NeoGuide’s full profile, request a free trial.
NeoGuide Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 01-Jun-2009 | 000.00 | Completed | Generating Revenue | ||
| 6. Debt - General | 13-Nov-2008 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series C) | 21-Sep-2006 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 4. Bridge | 07-Feb-2006 | 000 | 000.00 | Completed | Generating Revenue | |
| 3. Early Stage VC (Series B) | 22-Jun-2005 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 2. Early Stage VC (Series B) | 12-Dec-2003 | $14M | $17.2M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 13-Jun-2002 | $3.25M | $3.25M | 00.000 | Completed | Product Development |
NeoGuide Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A | 3,570,000 | $0.001000 | $0.08 | $0.4 | $1 | 2x | $0.4 | 3.05% |
NeoGuide Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| 3i Group | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| Advent Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Arboretum Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| DC Capital Partners | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| Kaiser Permanente Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
NeoGuide Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Amir Belson MD | Co-Founder, Chief Technology Officer, President & Board Member |
NeoGuide Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Amir Belson MD | Self | Co-Founder, Chief Technology Officer, President & Board Member | 000 0000 |
1 Former Board Member
You’re viewing 1 of 2 board members. Get the full list »